'Doubling down' on the autophagy pathway to suppress tumor growth

Andrew M Leidal1, Jayanta Debnath1

  • 1Department of Pathology, Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California 94143, USA.

Genes & Development
|June 4, 2014
PubMed

Insights

Researchers found that deleting the autophagy gene FIP200 and the p62/SQSTM1 adaptor protein together unexpectedly boosted tumor growth. This suggests dual targeting of autophagy and p62 could be a novel cancer treatment strategy.

Area of Science:

  • Molecular biology
  • Cancer research
  • Cellular processes

Background:

  • Autophagy is a cellular degradation process crucial for maintaining homeostasis.
  • p62/SQSTM1 is a key signaling adaptor protein involved in various cellular functions, including autophagy.
  • Dysregulation of autophagy and p62 has been implicated in cancer development and progression.

Purpose of the Study:

  • To investigate the combined role of the essential autophagy gene FIP200 and the signaling adaptor p62/SQSTM1 in established murine tumors.
  • To determine the synergistic effects of targeting both autophagy and p62 on tumor growth.

Main Methods:

  • Utilized elegant genetic approaches in murine models.
  • Simultaneously deleted the FIP200 gene and the p62/SQSTM1 gene within established tumors.

Main Results:

  • Demonstrated an unexpected synergism between the autophagy pathway and p62 in driving tumor growth.
  • Observed that combined deletion of FIP200 and p62 significantly impacted tumor progression.

Conclusions:

  • The interplay between autophagy and p62 is critical for tumor growth.
  • Combined targeting of autophagy and p62 presents a potential therapeutic strategy for specific cancers.

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.5K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
7.6K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.3K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.2K